The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
Open accessAbstract
The broad nature of insulin resistant glucose metabolism in skeletal muscle of patients with type 2 diabetes suggests a defect in the proximal part of the insulin signaling network. We sought to identify the pathways compromised in insulin resistance and to test the effect of moderate exercise on whole-body and cellular insulin action. We conducted euglycemic clamps and muscle biopsies on type 2 diabetic patients, obese nondiabetics and lean controls, with and without a single bout of exercise. Insulin stimulation of the phosphatidylinositol 3-kinase (PI 3-kinase) pathway, as measured by phosphorylation of the insulin receptor and IRS-1 and by IRS protein association with p85 and with PI 3-kinase, was dramatically reduced in obese nondiabetics and virtually absent in type 2 diabetic patients. Insulin stimulation of the MAP kinase pathway was normal in obese and diabetic subjects. Insulin stimulation of glucose-disposal correlated with association of p85 with IRS-1. Exercise 24 hours before the euglycemic clamp increased phosphorylation of insulin receptor and IRS-1 in obese and diabetic subjects but did not increase glucose uptake or PI 3-kinase association with IRS-1 upon insulin stimulation. Thus, insulin resistance differentially affects the PI 3-kinase and MAP kinase signaling pathways, and insulin-stimulated IRS-1-association with PI 3-kinase defines a key step in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using the euglycemic insulin clamp with skeletal muscle biopsy, a number of investigators have examined the insulin signal transduction system in human skeletal muscle of type 2 diabetic subjects and consistently demonstrated defects in IRS-1 tyrosine phosphorylation and PI-3 kinase and Akt activation ( 26 , 54 , 55 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [54]
Experimental — accuracy not yet measuredIn the citing paper
“In contrast, as the MAPK pathway has normal sensitivity to insulin, hyperinsulinemia activates the MAPK pathway, promoting vascular smooth muscle cell growth and activating inflammatory pathways, such as IkB/NF-kB and JNK [107,108].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [107]
In the citing paper
“Insulin resistance in skeletal muscle is manifested by decreased insulin-stimulated glucose uptake and results from impaired insulin signaling and multiple post-receptor intracellular defects including impaired glucose transport, glucose phosphorylation, and reduced glucose oxidation and glycogen synthesis.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Association of the p85 subunit of PI3K with IRS-1 and activation of PI3K also are greatly attenuated in obese nondiabetic and type 2 diabetic subjects compared with lean healthy controls [7, 165, 166].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“The ability of insulin to activate insulin receptor and IRS-1 tyrosine phosphorylation in muscle in obese nondiabetic subjects is modestly reduced; whereas in type 2 diabetics insulin-stimulated insulin receptor and IRS-1 tyrosine phosphorylation are severely impaired [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Most [1, 7, 152, 153, 156, 161] but not all [155] investigators have found a reduction in tyrosine kinase activity that cannot be explained by alterations in insulin receptor number or insulin receptor binding affinity.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“In insulin-resistant obese nondiabetic subjects, in the NGT insulin resistant offspring of two diabetic parents, and in type 2 diabetic subjects, a substantial decrease in insulin receptor tyrosine phosphorylation has been demonstrated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“The decrease in insulin-stimulated association of the p85 regulatory subunit of PI3K with IRS-1 is closely correlated with the reduction in insulin-stimulated muscle glycogen synthase activity and in vivo insulin-stimulated glucose disposal [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Intact stimulation of the MAPK pathway by insulin in the presence of insulin resistance in the PI3K pathway may play an important role in the development of atherosclerosis [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Insulin resistance in the PI3K signaling pathway contrasts with an intact stimulation of the MAPK pathway by insulin in insulin-resistant type 2 diabetic and obese nondiabetics individuals [7, 165].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Under basal conditions, total glycogen synthase activity in type 2 diabetic subjects is reduced, and the ability of insulin to activate glycogen synthase is severely impaired [7, 215–217].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252
Self-citationCheatham, B., Vlahos, C. J., Cheatham, L. A., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902-4911.1994 · Cited by 1,062
Self-citationMeasurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Perseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., & Shulman, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351804 · Cited by 699
Jiang, Z. Y., Lin, Y.-W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5971 · Cited by 604
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561
Effect of physical exercise on sensitivity and responsiveness to insulin in humans
Mikines, K. J., Sonne, B., Farrell, P. A., Tronier, B., & Galbo, H. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.254.3.e248 · Cited by 538
Goodyear, L. J., Giorgino, F., Sherman, L., Carey, J., Smith, R. J., & Dohm, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117909 · Cited by 527
Ren, J., Semenkovich, C. F., Gulve, E. A., Gao, J. H., & Holloszy, J. O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36636-x · Cited by 416
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 9
- Cheatham, 1994, Mol Cell Biol, 14, 4902, 10.1128/MCB.14.7.4902 · DOI
- Nyomba, 1990, Am J Physiol, 258, E964
- Hayashi, 1997, Am J Physiol, 273, E1039
- Koval, 1998, Am J Physiol, 274, E304
- O’Doherty, 1994, Am J Physiol, 266, E171
- Mikines, 1988, Am J Physiol, 254, E248
- Goodyear, 1995, Am J Physiol, 268, E987
- Zorzano, 1986, Am J Physiol, 251, E664
- Kochan, 1979, Am J Physiol, 236, E660
Cited by
Sorted by citations
Items 201–300 of 997
Paolo, S. D., Teutonico, A., Leogrande, D., Capobianco, C., & Schena, P. F. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030196 · Cited by 121
Insulin Receptor Isoforms in Cancer
Vella, V., Milluzzo, A., Scalisi, N. M., Vigneri, P. G., & Sciacca, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113615 · Cited by 120
AMP activated protein kinase: a next generation target for total metabolic control
Misra, P. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.1.91 · Cited by 117
Pratipanawatr, W., Pratipanawatr, T., Cusi, K., Berria, R., Adams, J. M., Jenkinson, C. P., Maezono, K., DeFronzo, R. A., & Mandarino, L. J. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2572 · Cited by 118
Self-citationMetabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes
Bakar, M. H. A., Sarmidi, M. R., Cheng, K., Khan, A. A., Suan, C. L., Huri, H. Z., & Yaakob, H. (2015) · Molecular BioSystems · doi:10.1039/c5mb00158g · Cited by 120
Muniyappa, R., Chen, H., Montagnani, M., Sherman, A., & Quon, M. J. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00247.2020 · Cited by 134
Barber, T. M., Dimitriadis, G. K., Andreou, A., & Franks, S. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-3-262 · Cited by 118
Eringa, E. C., Bakker, W., Smulders, Y. M., Serné, E. H., Yudkin, J. S., & Stehouwer, C. D. A. (2007) · Microcirculation · doi:10.1080/10739680701303584 · Cited by 116
Barber, T. M., Dimitriadis, G. K., Andreou, A., & Franks, S. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-6-s72 · Cited by 116
Effects of Polyphenols on Insulin Resistance
Williamson, G., & Sheedy, K. (2020) · Nutrients · doi:10.3390/nu12103135 · Cited by 126
Endothelial dysfunction in type 2 diabetes mellitus
Avogaro, A., Fadini, G. P., Gallo, A., Pagnin, E., & de Kreutzenberg, S. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.015 · Cited by 116
Immunocytochemical Detection of Phosphatidylinositol 3-kinase Activation by Insulin and Leptin
Niswender, K. D., Gallis, B. M., Blevins, J. E., Corson, M. A., Schwartz, M. W., & Baskin, D. G. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100302 · Cited by 115
Allister, E. M., Borradaile, N. M., Edwards, J. Y., & Huff, M. W. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1676 · Cited by 116
Dietary Flavonoids in the Prevention of T2D: An Overview
Alkhalidy, H., Wang, Y., & Liu, D. (2018) · Nutrients · doi:10.3390/nu10040438 · Cited by 123
Characterization of a TiO2 enrichment method for label-free quantitative phosphoproteomics
Montoya, A., Beltran, L., Casado, P., Rodríguez‐Prados, J., & Cutillas, P. R. (2011) · Methods · doi:10.1016/j.ymeth.2011.02.004 · Cited by 115
PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
Altalhi, R., Pechlivani, N., & Ajjan, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063170 · Cited by 115
Vascular insulin resistance: A potential link between cardiovascular and metabolic diseases
Schulman, I. H., & Zhou, M.-S. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0010-0 · Cited by 114
Caballero, A. E. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0074-9 · Cited by 114
Reversibility of endothelial dysfunction in diabetes: role of polyphenols
Suganya, N., Bhakkiyalakshmi, E., Sarada, D. V. L., & Ramkumar, K. M. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516001884 · Cited by 116
Potashnik, R., Bloch-Damti, A., Bashan, N., & Rudich, A. (2003) · Diabetologia · doi:10.1007/s00125-003-1097-5 · Cited by 111
Glycemic Control and Burnt‐Out Diabetes in ESRD
Kovesdy, C. P., Park, J. C., & Kalantar‐Zadeh, K. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00701.x · Cited by 113
Insulin and Endothelin: An Interplay Contributing to Hypertension Development?
Sarafidis, P. A., & Bakris, G. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1819 · Cited by 108
Batista, T. M., Jayavelu, A. K., Albrechtsen, N. J. W., Iovino, S., Lebastchi, J., Pan, H., Dreyfuss, J. M., Krook, A., Zierath, J. R., Mann, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.007 · Cited by 112
Self-citationBurn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle
Sugita, H., Kaneki, M., Sugita, M., Yasukawa, T., Yasuhara, S., & Martyn, J. A. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00321.2004 · Cited by 110
Jiang, G., Dallas-Yang, Q., Li, Z., Szalkowski, D., Liu, F., Shen, X., Wu, M. S., Zhou, G., Doebber, T. W., Berger, J., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2412 · Cited by 106
Lasram, M. M., Dhouib, I. B., Annabi, A. B., Fazâa, S. E., & Gharbi, N. (2014) · Toxicology · doi:10.1016/j.tox.2014.04.009 · Cited by 108
Magkos, F., Tsekouras, Y., Kavouras, S. A., Mittendorfer, B., & Sidossis, L. S. (2007) · Clinical Science · doi:10.1042/cs20070134 · Cited by 112
Federici, M., Pandolfi, A., Filippis, E. A. D., Pellegrini, G., Menghini, R., Lauro, D., Cardellini, M., Romano, M., Sesti, G., Lauro, R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000109498.77895.6f · Cited by 107
Eringa, E. C., Stehouwer, C. D. A., van Nieuw Amerongen, G. P., Ouwehand, L., Westerhof, N., & Sipkema, P. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00067.2004 · Cited by 107
Cozzone, D., Fröjdö, S., Disse, E., Debard, C., Laville, M., Pirola, L., & Vidal, H. (2008) · Diabetologia · doi:10.1007/s00125-007-0913-8 · Cited by 111
Hançer, N. J., Qiu, W., Cherella, C. E., Li, Y., Copps, K. D., & White, M. F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554162 · Cited by 120
Influence of Acute and Chronic Exercise on Glucose Uptake
Röhling, M., Herder, C., Stemper, T., & Müssig, K. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2868652 · Cited by 114
Nicolson, G. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21247 · Cited by 108
Koistinen, H. A., Chibalin, A., & Zierath, J. R. (2003) · Diabetologia · doi:10.1007/s00125-003-1196-3 · Cited by 108
Rho‐kinase as a molecular target for insulin resistance and hypertension
Kanda, T., Wakino, S., Homma, K., Yoshioka, K., Tatematsu, S., Hasegawa, K., Takamatsu, I., Sugano, N., Hayashi, K., & Saruta, T. (2005) · The FASEB Journal · doi:10.1096/fj.05-4197fje · Cited by 107
Iantorno, M., Chen, H., Kim, J., Tesauro, M., Lauro, D., Cardillo, C., & Quon, M. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00570.2006 · Cited by 107
Jin, W., Goldfine, A. B., Boes, T., Henry, R. R., Ciaraldi, T. P., Kim, E. Y., Şanlı, M. E., Fitzpatrick, C., Sen, A., Shah, A. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41940 · Cited by 107
Self-citationAcute insulin resistance following injury
Li, L., & Messina, J. L. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.06.004 · Cited by 109
Calcineurin Inhibition and New-Onset Diabetes Mellitus After Transplantation
Chakkera, H. A., & Mandarino, L. J. (2012) · Transplantation · doi:10.1097/tp.0b013e31826e592e · Cited by 109
Self-citationClinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients
Sciacca, L., Vigneri, R., Tumminia, A., Frasca, F., Squatrito, S., Frittitta, L., & Vigneri, P. G. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.05.006 · Cited by 105
Kashyap, S. R., Belfort, R., Berria, R., Suraamornkul, S., Pratipranawatr, T., Finlayson, J., Barrentine, A., Bajaj, M., Mandarino, L., DeFronzo, R., et al. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00541.2003 · Cited by 103
Self-citationInsulin Resistance and Improvements in Signal Transduction
Musi, N., & Goodyear, L. J. (2006) · Endocrine · doi:10.1385/endo:29:1:73 · Cited by 104
Gonzalez, E., Maratos–Flier, E., Molle, D., Accili, D., & McGraw, T. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019268108 · Cited by 104
Therapeutic Manipulation of Myocardial Metabolism
Honka, H., Solis‐Herrera, C., Triplitt, C. L., Norton, L., Butler, J., & DeFronzo, R. A. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.057 · Cited by 101
Self-citationAssociation between markers of glucose metabolism and risk of colorectal cancer
Xu, J., Yao, Y., Wu, H., Duerksen-Hughes, P. J., Zhang, H., Li, P., Huang, J., Yang, J. J., Wu, Y., & Xia, D. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011430 · Cited by 109
Counterpoint: Visceral Adiposity Is Not Causally Related to Insulin Resistance
Miles, J. M., & Jensen, M. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2326 · Cited by 102
Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus
Endemann, D., & Schiffrin, E. L. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0081-x · Cited by 99
Pourcet, B., Fruchart, J., Staels, B., & Glineur, C. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.3.379 · Cited by 102
The Insulin Receptor: A New Target for Cancer Therapy
Malaguarnera, R., & Belfiore, A. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00093 · Cited by 98
Filippis, E. D., Cusi, K. J., Ocampo, G. L., Berria, R., Buck, S. J., Consoli, A., & Mandarino, L. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1142 · Cited by 96
Self-citationOchiai, H., Okada, S., Saito, A. M., Hoshi, K., Yamashita, H., Takato, T., & Azuma, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.279091 · Cited by 97
Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo
Coletta, D. K., Balas, B., Chávez, A. O., Baig, M. R., Abdul‐Ghani, M. A., Kashyap, S., Folli, F. B., Tripathy, D., Mandarino, L. J., Cornell, J. E., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00607.2007 · Cited by 97
Self-citationMadonna, R., Pandolfi, A., Massaro, M., Consoli, A., & Caterina, R. D. (2004) · Diabetologia · doi:10.1007/s00125-004-1330-x · Cited by 96
Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications
Sidiropoulos, P. I., Karvounaris, S. A., & Boumpas, D. T. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2397 · Cited by 96
He, Z., Opland, D. M., Way, K. J., Ueki, K., Bodyak, N., Kang, P. M., Izumo, S., Kulkarni, R. N., Wang, B., Liao, R., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000209500.15801.4e · Cited by 94
Self-citationAye, I. L. M. H., Jansson, T., & Powell, T. L. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.013 · Cited by 96
Endothelial Dysfunction in Metabolic and Vascular Disorders
Polovina, M. M., & Potpara, T. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.03.2739 · Cited by 97
Excess Accumulation of Lipid Impairs Insulin Sensitivity in Skeletal Muscle
Park, S. S., & Seo, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061949 · Cited by 111
Karlsson, H., Hällsten, K., Björnholm, M., Tsuchida, H., Chibalin, A., Virtanen, K. A., Heinonen, O. J., Lönnqvist, F., Nuutila, P., & Zierath, J. R. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1459 · Cited by 92
Christ-Roberts, C. Y., Hunt, D. G., Hancock, J., García-Macedo, R., Mandarino, L. J., & Ivy, J. L. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00784.2001 · Cited by 91
Self-citationPendergrass, M., Bertoldo, A., Bonadonna, R., Nucci, G., Mandarino, L., Cobelli, C., & DeFronzo, R. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00617.2005 · Cited by 87
Self-citationEndothelial Dysfunction in Diabetes
Takeda, Y., Matoba, K., Sekiguchi, K., Nagai, Y., Yokota, T., Utsunomiya, K., & Nishimura, R. (2020) · Biomedicines · doi:10.3390/biomedicines8070182 · Cited by 96
Coletta, D. K., & Mandarino, L. J. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00363.2011 · Cited by 90
Self-citationLee, J. O., Lee, H. J., Lee, Y. W., Han, J. A., Kang, M. J., Moon, J., Shin, M.-J., Lee, H. J., Chung, J. H., Lee, J., et al. (2020) · FEBS Journal · doi:10.1111/febs.15301 · Cited by 97
Shen, N., Yu, X., Pan, F., Gao, X., Xue, B., & Li, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190165 · Cited by 91
Metabolic syndrome and endothelial dysfunction
Fornoni, A., & Raij, L. R. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0080-6 · Cited by 93
Glycemic Management in ESRD and Earlier Stages of CKD
Williams, M. E., & Garg, R. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.049 · Cited by 89
Danielsson, A., Öst, A., Nyström, F. H., & Strålfors, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500230200 · Cited by 89
Metabolic actions of angiotensin II and insulin: A microvascular endothelial balancing act
Muniyappa, R., & Yavuz, S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.05.017 · Cited by 96
Glycemic Control in Diabetic CKD Patients: Where Do We Stand?
Kovesdy, C. P., Sharma, K., & Kalantar‐Zadeh, K. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.04.011 · Cited by 88
Walter, L. C., Lindquist, K. J., & Covinsky, K. E. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-9-200405040-00007 · Cited by 87
Transcriptional and posttranscriptional regulation of the plasminogen activator system
Medcalf, R. L., Muñoz‐Cánoves, P., & Nagamine, Y. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0814 · Cited by 90
Effects of fasting on insulin action and glucose kinetics in lean and obese men and women
Bergman, B. C., Cornier, M.-A., Horton, T. J., & Bessesen, D. H. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00613.2006 · Cited by 87
Hsieh, P.-L., Tseng, C., Tseng, Y. J., & Yang, W. (2016) · Journal of Geriatric Physical Therapy · doi:10.1519/jpt.0000000000000107 · Cited by 92
Bell, J. A., Reed, M. A., Consitt, L. A., Martin, O. J., Haynie, K. R., Hulver, M. W., Muoio, D. M., & Dohm, G. L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1596 · Cited by 88
Ceolotto, G., Bevilacqua, M., Papparella, I., Baritono, E., Franco, L., Corvaja, C., Mazzoni, M., Semplicini, A., & Avogaro, A. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1344 · Cited by 87
Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis
Lomonaco, R., Ortiz‐Lopez, C., Orsak, B., Finch, J., Webb, A., Bril, F., Louden, C., Tio, F. O., & Cusi, K. J. (2011) · Hepatology · doi:10.1002/hep.24483 · Cited by 86
Self-citationAgeing and metabolism: drug discovery opportunities
Curtis, R., Geesaman, B. J., & DiStefano, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1777 · Cited by 86
Potenza, M. A., Marasciulo, F. L., Tarquinio, M., Quon, M. J., & Montagnani, M. (2006) · Diabetes · doi:10.2337/db06-0667 · Cited by 87
Danielsson, A., Öst, A., Lystedt, E., Kjølhede, P., Gustavsson, J., Nyström, F. H., & Strålfors, P. (2004) · FEBS Journal · doi:10.1111/j.1432-1033.2004.04396.x · Cited by 85
Protocatechuic acid activates key components of insulin signaling pathway mimicking insulin activity
Scazzocchio, B., Varı́, R., Filesi, C., Gaudio, I. D., D’Archivio, M., Santangelo, C., Iacovelli, A., Galvano, F., Pluchinotta, F. R., Giovannini, C., et al. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400816 · Cited by 84
Revista Latinoamericana de Hipertensión
Velasco, M., Hernández, R. H., Armas, M. J., Zafar, I., Levenson, J. A., Venkata, R., Celso, A., Valmore, B., María, C. A., Norman, K., et al. (2007) · Cited by 83
Tripathy, D., Daniele, G., Fiorentino, T. V., Perez-Cadena, Z., Chavez-Velasquez, A., Kamath, S., Fanti, P., Jenkinson, C. P., Andreozzi, F., Federici, M., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-2976-z · Cited by 83
Self-citationAbdul-Ghani, M. A., Jani, R., Chavez, A., Molina-Carrion, M., Tripathy, D., & DeFronzo, R. A. (2009) · Diabetologia · doi:10.1007/s00125-009-1264-4 · Cited by 83
Self-citationWilliams, K. J., & Wu, X. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.004 · Cited by 83
Højlund, K., Bowen, B. P., Hwang, H., Flynn, C. R., Madireddy, L., Geetha, T., Langlais, P. R., Meyer, C., Mandarino, L. J., & Yi, Z. (2009) · Journal of Proteome Research · doi:10.1021/pr9007267 · Cited by 85
Self-citationPalmitate and insulin synergistically induce IL-6 expression in human monocytes
Bunn, R. C., Cockrell, G. E., Ou, Y., Thrailkill, K. M., Lumpkin, C. K., & Fowlkes, J. L. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-73 · Cited by 86
Caballero, A. E. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.03.013 · Cited by 82
Storgaard, H., Song, X. M., Jensen, C. B., Madsbad, S., Björnholm, M., Vaag, A. A., & Zierath, J. R. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2770 · Cited by 82
Fazakerley, D. J., van Gerwen, J., Cooke, K. C., Duan, X., Needham, E. J., Díaz‐Vegas, A., Madsen, S., Norris, D. M., Shun-Shion, A. S., Krycer, J. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36549-2 · Cited by 83
de Laat, M. A., Eps, A. W. V., McGowan, C. M., Sillence, M. N., & Pollitt, C. C. (2011) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2011.02.001 · Cited by 81
Duncan, E. R., Walker, S. J., Ezzat, V., Wheatcroft, S. B., Li, J., Shah, A. M., & Kearney, M. T. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00299.2007 · Cited by 79
Kiràly, M. A., Bates, H. E., Yue, J. T. Y., Montes, D. G., Fediuc, S., Park, E., Matthews, S. G., Vranić, M., & Riddell, M. C. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.022 · Cited by 77
Effects of insulin resistance on endothelial progenitor cells and vascular repair
Cubbon, R. M., Kahn, M., & Wheatcroft, S. B. (2009) · Clinical Science · doi:10.1042/cs20080263 · Cited by 81
Insulin-stimulated glucose uptake in healthy and insulin-resistant skeletal muscle
Deshmukh, A. S. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0041 · Cited by 84
Alexandru, N., Bădilă, E., Weiss, E., Cochior, D., Stępień, E. Ł., & Georgescu, A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.038 · Cited by 79
Bedinger, D., & Adams, S. H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.08.013 · Cited by 85
General aspects of muscle glucose uptake
Alvim, R. D. O., CHEUHEN, M. R., MACHADO, S. R., de Sousa, A. G. P., & SANTOS, P. C. J. L. (2015) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201520140225 · Cited by 92
The role of AMP kinase in diabetes.
Misra, P., & Chakrabarti, R. (2007) · PubMed · Cited by 78
Insulin resistance and endothelial dysfunction
Yki‐Järvinen, H. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00033-2 · Cited by 77
Metadata
- Authors
- Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Harvard University (US)
- Tulane University (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Mandarino, Lawrence J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2000-02-01
- Volume
- 105
- Issue
- 3
- Pages
- 311-320
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC377440
- OpenAlex
- W2120852510
- Cited by
- 1,139
- References
- 48
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 19 · 2023: 27 · 2022: 35 · 2021: 45 · 2020: 33 · 2019: 35 · 2018: 24 · 2017: 37 · 2016: 52 · 2015: 54 · 2014: 53 · 2013: 57 · 2012: 65
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (5k08dk002526-03)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-24092, DK02526, R01DK047936, R01DK033201, R01DK024092, R01-DK-47936)
- National Center for Research Resources (M01RR001346)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin resistance, skeletal muscle, type 2 diabetes, PI3K signaling, MAPK signaling, insulin receptor, IRS-1, p85 regulatory subunit, physical activity, glucose uptake, obesity, euglycemic clamp, insulin signaling
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Phosphoproteins, Receptor, Insulin, Signal Transduction, Muscle, Skeletal, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
